BioCentury
ARTICLE | Clinical News

CVBT-141B: Phase IIb data

January 10, 2011 8:00 AM UTC

In a double-blind Phase IIb trial, diabetic wounds treated with CVBT-141B achieved 100% closure in <=5 months compared with 33% of the placebo group whose wounds remained open. Additionally, 57% of pa...